Review



nelf e antibody  (Abcam)


Bioz Verified Symbol Abcam is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Abcam nelf e antibody
    a Western blot analysis <t>of</t> <t>NELF-A</t> and <t>NELF-E</t> in non-tumorigenic breast epithelial cell line MCF10A, as well as in different breast cancer cell lines T-47D (ER + , PR + ), SK-BR-3 (HER2 + ), MCF7 (ER + ), BT-474 (HER2 + ), BT-549 (triple-negative), MDA-MB-231 (triple-negative), and SUM159 (triple-negative). β-actin was used as the loading control. b , c Left: MCF7 cells ( n = 3) and BT-549 cells ( n = 4) were transfected with non-targeting siRNA (‘scrambled, siSCR’) and siRNAs targeting NELF-A and NELF-E, respectively, followed by western blot analysis. GAPDH was used as the loading control. Right: Representative images and quantification of soft agar assays. d Left: Western blot analysis of NELF-A, NELF-E, NELF-B, and NELF-C/D in WT and NELF-A/NELF-E KO SUM159 cells. β-actin was used as the loading control. Right: Representative images and quantification of soft agar assays ( n = 4). e 5 × 10 6 WT, NELF-A KO, and NELF-E KO SUM159 cells were injected into the mammary fat pads of NOD/SCID mice, respectively. Tumor volume was measured every 3 days after the tumor was palpable; mean ± SEM, n = 4/group. f Left: Tumors harvested from WT, NELF-A KO, and NELF-E KO groups; Right: Quantification of tumor weights; mean ± SEM, n = 4/group. Blots and images are representative of at least three independent experiments. Data in ( b – d ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.
    Nelf E Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 163 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nelf e antibody/product/Abcam
    Average 99 stars, based on 163 article reviews
    nelf e antibody - by Bioz Stars, 2026-05
    99/100 stars

    Images

    1) Product Images from "Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis"

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    Journal: Nature Communications

    doi: 10.1038/s41467-023-38132-1

    a Western blot analysis of NELF-A and NELF-E in non-tumorigenic breast epithelial cell line MCF10A, as well as in different breast cancer cell lines T-47D (ER + , PR + ), SK-BR-3 (HER2 + ), MCF7 (ER + ), BT-474 (HER2 + ), BT-549 (triple-negative), MDA-MB-231 (triple-negative), and SUM159 (triple-negative). β-actin was used as the loading control. b , c Left: MCF7 cells ( n = 3) and BT-549 cells ( n = 4) were transfected with non-targeting siRNA (‘scrambled, siSCR’) and siRNAs targeting NELF-A and NELF-E, respectively, followed by western blot analysis. GAPDH was used as the loading control. Right: Representative images and quantification of soft agar assays. d Left: Western blot analysis of NELF-A, NELF-E, NELF-B, and NELF-C/D in WT and NELF-A/NELF-E KO SUM159 cells. β-actin was used as the loading control. Right: Representative images and quantification of soft agar assays ( n = 4). e 5 × 10 6 WT, NELF-A KO, and NELF-E KO SUM159 cells were injected into the mammary fat pads of NOD/SCID mice, respectively. Tumor volume was measured every 3 days after the tumor was palpable; mean ± SEM, n = 4/group. f Left: Tumors harvested from WT, NELF-A KO, and NELF-E KO groups; Right: Quantification of tumor weights; mean ± SEM, n = 4/group. Blots and images are representative of at least three independent experiments. Data in ( b – d ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.
    Figure Legend Snippet: a Western blot analysis of NELF-A and NELF-E in non-tumorigenic breast epithelial cell line MCF10A, as well as in different breast cancer cell lines T-47D (ER + , PR + ), SK-BR-3 (HER2 + ), MCF7 (ER + ), BT-474 (HER2 + ), BT-549 (triple-negative), MDA-MB-231 (triple-negative), and SUM159 (triple-negative). β-actin was used as the loading control. b , c Left: MCF7 cells ( n = 3) and BT-549 cells ( n = 4) were transfected with non-targeting siRNA (‘scrambled, siSCR’) and siRNAs targeting NELF-A and NELF-E, respectively, followed by western blot analysis. GAPDH was used as the loading control. Right: Representative images and quantification of soft agar assays. d Left: Western blot analysis of NELF-A, NELF-E, NELF-B, and NELF-C/D in WT and NELF-A/NELF-E KO SUM159 cells. β-actin was used as the loading control. Right: Representative images and quantification of soft agar assays ( n = 4). e 5 × 10 6 WT, NELF-A KO, and NELF-E KO SUM159 cells were injected into the mammary fat pads of NOD/SCID mice, respectively. Tumor volume was measured every 3 days after the tumor was palpable; mean ± SEM, n = 4/group. f Left: Tumors harvested from WT, NELF-A KO, and NELF-E KO groups; Right: Quantification of tumor weights; mean ± SEM, n = 4/group. Blots and images are representative of at least three independent experiments. Data in ( b – d ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.

    Techniques Used: Western Blot, Transfection, Injection, Two Tailed Test

    a MA plot showing gene expression changes between NELF-E KO and WT SUM159 cells. Red and blue points indicate significantly upregulated ( n = 388) and downregulated ( n = 540) genes, respectively. b GSEA enrichment plot for stemness and epithelial-mesenchymal transition pathways in NELF-E KO SUM159 cells. c Western blot analysis of NELF-E and NELF-A in WT, NELF-E KO, and NELF-E rescue SUM159 cells. β-actin was used as the loading control. d Quantification of wound healing assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells. Scale bar = 100 μm. e Quantification of mammosphere formation assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 4). Scale bar = 100 μm. f Quantification of invasion assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 3). Scale bar = 100 μm. g Body weight (mean ± SEM) of mice injected with 1.25 × 10 6 WT and NELF-E KO SUM159 cells, respectively ( n = 8, each group). h Lungs inflated and fixed with 10% neutral buffer formalin from mice in WT ( n = 8) and NELF-E KO group ( n = 8). i Representative images of H&E staining in lung tissues at three magnifications (mf: metastatic foci). From top to bottom, Bar = 2 mm, 500 μm, and 100 μm, respectively. j Quantitative analysis of lung metastasis presented as % of occupation by metastasis and the number of metastatic sites per lung ( n = 8/group). k Graph showing quantification of mammospheres in WT, NELF-E KO, and NELF-E rescue MCF7 cells at primary ( n = 3), secondary ( n = 4), and tertiary passages ( n = 4). l MCF7 cells from tertiary spheroids were seeded at a density of 1000 cells per well and incubated for 2 weeks. The colonies were then fixed and stained with crystal violet. m Flow cytometry analysis and quantification of the CD24 low /CD44 high population in MCF7 tertiary mammospheres ( n = 3). Blots and images are representative of at least three independent experiments. Data in ( d , e , f , j , k , m ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.
    Figure Legend Snippet: a MA plot showing gene expression changes between NELF-E KO and WT SUM159 cells. Red and blue points indicate significantly upregulated ( n = 388) and downregulated ( n = 540) genes, respectively. b GSEA enrichment plot for stemness and epithelial-mesenchymal transition pathways in NELF-E KO SUM159 cells. c Western blot analysis of NELF-E and NELF-A in WT, NELF-E KO, and NELF-E rescue SUM159 cells. β-actin was used as the loading control. d Quantification of wound healing assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells. Scale bar = 100 μm. e Quantification of mammosphere formation assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 4). Scale bar = 100 μm. f Quantification of invasion assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 3). Scale bar = 100 μm. g Body weight (mean ± SEM) of mice injected with 1.25 × 10 6 WT and NELF-E KO SUM159 cells, respectively ( n = 8, each group). h Lungs inflated and fixed with 10% neutral buffer formalin from mice in WT ( n = 8) and NELF-E KO group ( n = 8). i Representative images of H&E staining in lung tissues at three magnifications (mf: metastatic foci). From top to bottom, Bar = 2 mm, 500 μm, and 100 μm, respectively. j Quantitative analysis of lung metastasis presented as % of occupation by metastasis and the number of metastatic sites per lung ( n = 8/group). k Graph showing quantification of mammospheres in WT, NELF-E KO, and NELF-E rescue MCF7 cells at primary ( n = 3), secondary ( n = 4), and tertiary passages ( n = 4). l MCF7 cells from tertiary spheroids were seeded at a density of 1000 cells per well and incubated for 2 weeks. The colonies were then fixed and stained with crystal violet. m Flow cytometry analysis and quantification of the CD24 low /CD44 high population in MCF7 tertiary mammospheres ( n = 3). Blots and images are representative of at least three independent experiments. Data in ( d , e , f , j , k , m ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.

    Techniques Used: Expressing, Western Blot, Wound Healing Assay, Tube Formation Assay, Invasion Assay, Injection, Staining, Incubation, Flow Cytometry, Two Tailed Test

    a Barplot showing the top perturbed pathways from Molecular Signatures Database (MSigDB) in Doxycycline (Dox)-treated MCF7ras+SS cells compared to the vehicle control. b Volcano plot depicting the significantly upregulated genes ( n = 1750) and downregulated genes ( n = 2223). Select mesenchymal/stemness-related genes are labeled in red, while epithelial genes are labeled in blue. adj. p -value ≤ 0.05; |fold change| ≥ 1.5. p -value was calculated using DESeq2 package (see details in “Methods”) c Western blot analysis for different markers in Dox-induced MCF7ras+SS cells transduced with scrambled or two independent shRNAs targeting NELF-E. GAPDH was used as the loading control. d GSEA plot of shNELF-E+Dox vs SCR+Dox cells. p -value was calculated from gene set enrichment analysis. (see detail in “Methods”). e Representative images and quantification of the migration and invasion assays. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA and treated with Dox to induce SOX9 and SLUG expression for 72 h prior to the assays ( n = 3). Scale Bar = 100 μm. f Representative images and quantification of the sphere-formation assay. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA, followed by 72-h Dox treatment. Cells were seeded at a density of 10K per well, and the number of spheres was counted 5–7 days later ( n = 4). Scale Bar = 100 μm. g Representative images and quantification of the soft agar assays for SCR+Dox and shNELF-E+Dox cells ( n = 3). h Flow cytometry analysis and quantification of the CD24 low /CD44 high population in NELF-E KD+Dox cells compared to SCR+Dox cells ( n = 3). Blots and images are representative of at least three independent experiments. p -values in ( e – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.
    Figure Legend Snippet: a Barplot showing the top perturbed pathways from Molecular Signatures Database (MSigDB) in Doxycycline (Dox)-treated MCF7ras+SS cells compared to the vehicle control. b Volcano plot depicting the significantly upregulated genes ( n = 1750) and downregulated genes ( n = 2223). Select mesenchymal/stemness-related genes are labeled in red, while epithelial genes are labeled in blue. adj. p -value ≤ 0.05; |fold change| ≥ 1.5. p -value was calculated using DESeq2 package (see details in “Methods”) c Western blot analysis for different markers in Dox-induced MCF7ras+SS cells transduced with scrambled or two independent shRNAs targeting NELF-E. GAPDH was used as the loading control. d GSEA plot of shNELF-E+Dox vs SCR+Dox cells. p -value was calculated from gene set enrichment analysis. (see detail in “Methods”). e Representative images and quantification of the migration and invasion assays. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA and treated with Dox to induce SOX9 and SLUG expression for 72 h prior to the assays ( n = 3). Scale Bar = 100 μm. f Representative images and quantification of the sphere-formation assay. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA, followed by 72-h Dox treatment. Cells were seeded at a density of 10K per well, and the number of spheres was counted 5–7 days later ( n = 4). Scale Bar = 100 μm. g Representative images and quantification of the soft agar assays for SCR+Dox and shNELF-E+Dox cells ( n = 3). h Flow cytometry analysis and quantification of the CD24 low /CD44 high population in NELF-E KD+Dox cells compared to SCR+Dox cells ( n = 3). Blots and images are representative of at least three independent experiments. p -values in ( e – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Techniques Used: Labeling, Western Blot, Transduction, Migration, shRNA, Expressing, Tube Formation Assay, Flow Cytometry, Two Tailed Test

    a Log 2 fold change of UP-genes ( n = 1750), DOWN-genes ( n = 2223), and unchanged genes ( n = 1581) in the two different conditions. Gene categorization was based on the condition of SCR+Dox vs SCR-Con with the cutoffs of adj. p -value ≤ 0.05 and |fold change| ≥ 1.5. Center lines show median values, box limits represent the upper and lower quartiles, and whiskers show 1.5× the interquartile range. Two-tailed Student’s t -tests were used for all comparisons. p -values were not adjusted for multiple tests, and t -statistics are provided in source data. b Genomic distribution of NELF-E binding sites in Dox-treated MCF7ras+SS cells. c Metagene plots of NELF-E ChIP-seq signals in SCR-Con and SCR+Dox cells for UP-genes (top panel) and DOWN-genes (bottom panel). d Metagene plots of RNAPII ChIP-seq signals in SCR-Con, SCR+Dox, and shNELF-E+Dox cells for UP-genes and DOWN-genes. e Genome browser tracks showing NELF-E and RNAPII occupancies at the promoters of mesenchymal gene FN1 (left) and stemness-related gene CD44 (right). Source data are provided as a Source Data file.
    Figure Legend Snippet: a Log 2 fold change of UP-genes ( n = 1750), DOWN-genes ( n = 2223), and unchanged genes ( n = 1581) in the two different conditions. Gene categorization was based on the condition of SCR+Dox vs SCR-Con with the cutoffs of adj. p -value ≤ 0.05 and |fold change| ≥ 1.5. Center lines show median values, box limits represent the upper and lower quartiles, and whiskers show 1.5× the interquartile range. Two-tailed Student’s t -tests were used for all comparisons. p -values were not adjusted for multiple tests, and t -statistics are provided in source data. b Genomic distribution of NELF-E binding sites in Dox-treated MCF7ras+SS cells. c Metagene plots of NELF-E ChIP-seq signals in SCR-Con and SCR+Dox cells for UP-genes (top panel) and DOWN-genes (bottom panel). d Metagene plots of RNAPII ChIP-seq signals in SCR-Con, SCR+Dox, and shNELF-E+Dox cells for UP-genes and DOWN-genes. e Genome browser tracks showing NELF-E and RNAPII occupancies at the promoters of mesenchymal gene FN1 (left) and stemness-related gene CD44 (right). Source data are provided as a Source Data file.

    Techniques Used: Two Tailed Test, Binding Assay, ChIP-sequencing

    a Volcano plot of NELF-E qPLEX-RIME analysis of WT+Dox vs WT-Con. Proteins that satisfy the significance threshold of |log 2 (fold change)| ≥0.5 and adj. p -value <0.05 are labeled with their gene names and colored red. The p -value was adjusted by Benjamini–Hochberg multiple hypothesis correction. b Interaction network plot of proteins enriched in Dox induction by qPLEX-RIME, superimposed on the STRING interaction network. Interactions detected by qPLEX-RIME are colored in blue, while interactions from the STRING database are colored in gray. Proteins/nodes are colored based on log 2 (fold change) value. c Western blot analysis of SOX9, SLUG, and NELF-E following NELF-E immunoprecipitation (IP), performed on nuclear extracts from Dox-treated MCF7ras+SS cells. Blots are representative of three independent experiments. d Genomic distribution of SLUG binding sites in MCF7ras+SS cells transduced with scrambled shRNA and treated with Dox (SCR+Dox). e Metaplots of SLUG binding across the three different categories in SCR+Dox and shNELF-E+Dox MCF7ras+SS cells. f , g Pie chart and heatmap depiction of SLUG and NELF-E co-bound peaks at TSS and distal regions. Source data are provided as a Source Data file.
    Figure Legend Snippet: a Volcano plot of NELF-E qPLEX-RIME analysis of WT+Dox vs WT-Con. Proteins that satisfy the significance threshold of |log 2 (fold change)| ≥0.5 and adj. p -value <0.05 are labeled with their gene names and colored red. The p -value was adjusted by Benjamini–Hochberg multiple hypothesis correction. b Interaction network plot of proteins enriched in Dox induction by qPLEX-RIME, superimposed on the STRING interaction network. Interactions detected by qPLEX-RIME are colored in blue, while interactions from the STRING database are colored in gray. Proteins/nodes are colored based on log 2 (fold change) value. c Western blot analysis of SOX9, SLUG, and NELF-E following NELF-E immunoprecipitation (IP), performed on nuclear extracts from Dox-treated MCF7ras+SS cells. Blots are representative of three independent experiments. d Genomic distribution of SLUG binding sites in MCF7ras+SS cells transduced with scrambled shRNA and treated with Dox (SCR+Dox). e Metaplots of SLUG binding across the three different categories in SCR+Dox and shNELF-E+Dox MCF7ras+SS cells. f , g Pie chart and heatmap depiction of SLUG and NELF-E co-bound peaks at TSS and distal regions. Source data are provided as a Source Data file.

    Techniques Used: Labeling, Western Blot, Immunoprecipitation, Binding Assay, Transduction, shRNA

    a Dot plot showing KAT2B as one of the top genes ( n = 41) whose SLUG-mediated activation was most significantly attenuated by NELF-E KD. Expressions of corresponding genes in the two comparisons are connected by gray lines. b Genome browser tracks showing the occupancies of NELF-E, SLUG, and RNAPII on the KAT2B locus. c RT-qPCR analysis (left) and western blot analysis (right) of KAT2B in MCF7ras+SS cells treated with Dox for different time points ( n = 3). d Western blot analysis of KAT2B in MCF7ras+SS cells transduced with scrambled shRNA or two independent NELF-E shRNAs and treated with or without Dox. GAPDH was used as the loading control. e Heatmap depiction of SLUG/NELF-E/KAT2B/RNAPII signals at NELF-E-alone, SLUG-alone and NELF-E/SLUG co-bound regions. f Metaplot of KAT2B ChIP-Seq signals over the different cohorts of SLUG-bound regions. g Venn diagram showing the overlap between SLUG-bound UP-genes and NELF-E/KAT2B targets. The percentage overlap of SLUG-bound UP-genes compared to other categories is also indicated. h Genome browser tracks showing the occupancies of NELF-E, SLUG, and KAT2B on LAMC1 and ZEB1 loci. Blots are representative of three independent experiments. p -values are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.
    Figure Legend Snippet: a Dot plot showing KAT2B as one of the top genes ( n = 41) whose SLUG-mediated activation was most significantly attenuated by NELF-E KD. Expressions of corresponding genes in the two comparisons are connected by gray lines. b Genome browser tracks showing the occupancies of NELF-E, SLUG, and RNAPII on the KAT2B locus. c RT-qPCR analysis (left) and western blot analysis (right) of KAT2B in MCF7ras+SS cells treated with Dox for different time points ( n = 3). d Western blot analysis of KAT2B in MCF7ras+SS cells transduced with scrambled shRNA or two independent NELF-E shRNAs and treated with or without Dox. GAPDH was used as the loading control. e Heatmap depiction of SLUG/NELF-E/KAT2B/RNAPII signals at NELF-E-alone, SLUG-alone and NELF-E/SLUG co-bound regions. f Metaplot of KAT2B ChIP-Seq signals over the different cohorts of SLUG-bound regions. g Venn diagram showing the overlap between SLUG-bound UP-genes and NELF-E/KAT2B targets. The percentage overlap of SLUG-bound UP-genes compared to other categories is also indicated. h Genome browser tracks showing the occupancies of NELF-E, SLUG, and KAT2B on LAMC1 and ZEB1 loci. Blots are representative of three independent experiments. p -values are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Techniques Used: Activation Assay, Quantitative RT-PCR, Western Blot, Transduction, shRNA, ChIP-sequencing, Two Tailed Test

    a GSEA plot showing significantly enriched pathways in siKAT2B+Dox vs siSCR+Dox MCF7ras+SS cells. p -value was calculated from gene set enrichment analysis (see details in “Methods”). b Western blot analysis of ECM1 and CD44 in MCF7ras+SS cells treated with or without GA and AA. GAPDH was used as the loading control. Images and blots are representative of three independent experiments. c qRT-PCR analysis of FN1 and ECM1 in GA- and AA-treated Dox-induced MCF7ras+SS cells ( n = 3). d Flow cytometry analysis and quantification of the CD24 low /CD44 high population in vehicle control, GA-, and AA-treated MCF7ras+SS cells, as a function of Dox induction. e Flow cytometry analysis and quantification of the CD24 low /CD44 high population following KAT2B overexpression in MCF7ras+SS cells. Vector control (GFP only; pCAGIG) and KAT2B-overexpression (KAT2B+GFP; pCAGIG-KAT2B) plasmids were transfected into MCF7ras+SS cells, respectively. The GFP − and GFP + populations were isolated and analyzed for the CD24 low /CD44 high population ( n = 3). f , g Patient-derived breast cancer organoids were transduced with scrambled shRNA or two independent KAT2B or NELF-E shRNAs, followed by western blot and sphere-formation assay ( n = 3). β-actin was used as the loading control. h Patient-derived breast cancer organoids were transduced with vector control or KAT2B overexpressing plasmid, followed by western blot and sphere-formation assay ( n = 4). GAPDH was used as the loading control. Blots and images are representative of at least three independent experiments. p -values in ( c – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.
    Figure Legend Snippet: a GSEA plot showing significantly enriched pathways in siKAT2B+Dox vs siSCR+Dox MCF7ras+SS cells. p -value was calculated from gene set enrichment analysis (see details in “Methods”). b Western blot analysis of ECM1 and CD44 in MCF7ras+SS cells treated with or without GA and AA. GAPDH was used as the loading control. Images and blots are representative of three independent experiments. c qRT-PCR analysis of FN1 and ECM1 in GA- and AA-treated Dox-induced MCF7ras+SS cells ( n = 3). d Flow cytometry analysis and quantification of the CD24 low /CD44 high population in vehicle control, GA-, and AA-treated MCF7ras+SS cells, as a function of Dox induction. e Flow cytometry analysis and quantification of the CD24 low /CD44 high population following KAT2B overexpression in MCF7ras+SS cells. Vector control (GFP only; pCAGIG) and KAT2B-overexpression (KAT2B+GFP; pCAGIG-KAT2B) plasmids were transfected into MCF7ras+SS cells, respectively. The GFP − and GFP + populations were isolated and analyzed for the CD24 low /CD44 high population ( n = 3). f , g Patient-derived breast cancer organoids were transduced with scrambled shRNA or two independent KAT2B or NELF-E shRNAs, followed by western blot and sphere-formation assay ( n = 3). β-actin was used as the loading control. h Patient-derived breast cancer organoids were transduced with vector control or KAT2B overexpressing plasmid, followed by western blot and sphere-formation assay ( n = 4). GAPDH was used as the loading control. Blots and images are representative of at least three independent experiments. p -values in ( c – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Techniques Used: Western Blot, Quantitative RT-PCR, Flow Cytometry, Over Expression, Plasmid Preparation, Transfection, Isolation, Derivative Assay, Transduction, shRNA, Tube Formation Assay, Two Tailed Test



    Similar Products

    93
    Santa Cruz Biotechnology nelfe
    Nelfe, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nelfe/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    nelfe - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology 2021 20 n a nelfe santa cruz biotechnology cat sc 32912
    2021 20 N A Nelfe Santa Cruz Biotechnology Cat Sc 32912, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2021 20 n a nelfe santa cruz biotechnology cat sc 32912/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    2021 20 n a nelfe santa cruz biotechnology cat sc 32912 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology anti nelf e
    Anti Nelf E, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti nelf e/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    anti nelf e - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    86
    Danaher Inc nelf e antibody
    Nelf E Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nelf e antibody/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    nelf e antibody - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    90
    Millipore nelf-e antibody
    Nelf E Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nelf-e antibody/product/Millipore
    Average 90 stars, based on 1 article reviews
    nelf-e antibody - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    99
    Abcam nelf e antibody
    a Western blot analysis <t>of</t> <t>NELF-A</t> and <t>NELF-E</t> in non-tumorigenic breast epithelial cell line MCF10A, as well as in different breast cancer cell lines T-47D (ER + , PR + ), SK-BR-3 (HER2 + ), MCF7 (ER + ), BT-474 (HER2 + ), BT-549 (triple-negative), MDA-MB-231 (triple-negative), and SUM159 (triple-negative). β-actin was used as the loading control. b , c Left: MCF7 cells ( n = 3) and BT-549 cells ( n = 4) were transfected with non-targeting siRNA (‘scrambled, siSCR’) and siRNAs targeting NELF-A and NELF-E, respectively, followed by western blot analysis. GAPDH was used as the loading control. Right: Representative images and quantification of soft agar assays. d Left: Western blot analysis of NELF-A, NELF-E, NELF-B, and NELF-C/D in WT and NELF-A/NELF-E KO SUM159 cells. β-actin was used as the loading control. Right: Representative images and quantification of soft agar assays ( n = 4). e 5 × 10 6 WT, NELF-A KO, and NELF-E KO SUM159 cells were injected into the mammary fat pads of NOD/SCID mice, respectively. Tumor volume was measured every 3 days after the tumor was palpable; mean ± SEM, n = 4/group. f Left: Tumors harvested from WT, NELF-A KO, and NELF-E KO groups; Right: Quantification of tumor weights; mean ± SEM, n = 4/group. Blots and images are representative of at least three independent experiments. Data in ( b – d ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.
    Nelf E Antibody, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nelf e antibody/product/Abcam
    Average 99 stars, based on 1 article reviews
    nelf e antibody - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    Abcam anti nelf e
    a Western blot analysis <t>of</t> <t>NELF-A</t> and <t>NELF-E</t> in non-tumorigenic breast epithelial cell line MCF10A, as well as in different breast cancer cell lines T-47D (ER + , PR + ), SK-BR-3 (HER2 + ), MCF7 (ER + ), BT-474 (HER2 + ), BT-549 (triple-negative), MDA-MB-231 (triple-negative), and SUM159 (triple-negative). β-actin was used as the loading control. b , c Left: MCF7 cells ( n = 3) and BT-549 cells ( n = 4) were transfected with non-targeting siRNA (‘scrambled, siSCR’) and siRNAs targeting NELF-A and NELF-E, respectively, followed by western blot analysis. GAPDH was used as the loading control. Right: Representative images and quantification of soft agar assays. d Left: Western blot analysis of NELF-A, NELF-E, NELF-B, and NELF-C/D in WT and NELF-A/NELF-E KO SUM159 cells. β-actin was used as the loading control. Right: Representative images and quantification of soft agar assays ( n = 4). e 5 × 10 6 WT, NELF-A KO, and NELF-E KO SUM159 cells were injected into the mammary fat pads of NOD/SCID mice, respectively. Tumor volume was measured every 3 days after the tumor was palpable; mean ± SEM, n = 4/group. f Left: Tumors harvested from WT, NELF-A KO, and NELF-E KO groups; Right: Quantification of tumor weights; mean ± SEM, n = 4/group. Blots and images are representative of at least three independent experiments. Data in ( b – d ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.
    Anti Nelf E, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti nelf e/product/Abcam
    Average 99 stars, based on 1 article reviews
    anti nelf e - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    Image Search Results


    a Western blot analysis of NELF-A and NELF-E in non-tumorigenic breast epithelial cell line MCF10A, as well as in different breast cancer cell lines T-47D (ER + , PR + ), SK-BR-3 (HER2 + ), MCF7 (ER + ), BT-474 (HER2 + ), BT-549 (triple-negative), MDA-MB-231 (triple-negative), and SUM159 (triple-negative). β-actin was used as the loading control. b , c Left: MCF7 cells ( n = 3) and BT-549 cells ( n = 4) were transfected with non-targeting siRNA (‘scrambled, siSCR’) and siRNAs targeting NELF-A and NELF-E, respectively, followed by western blot analysis. GAPDH was used as the loading control. Right: Representative images and quantification of soft agar assays. d Left: Western blot analysis of NELF-A, NELF-E, NELF-B, and NELF-C/D in WT and NELF-A/NELF-E KO SUM159 cells. β-actin was used as the loading control. Right: Representative images and quantification of soft agar assays ( n = 4). e 5 × 10 6 WT, NELF-A KO, and NELF-E KO SUM159 cells were injected into the mammary fat pads of NOD/SCID mice, respectively. Tumor volume was measured every 3 days after the tumor was palpable; mean ± SEM, n = 4/group. f Left: Tumors harvested from WT, NELF-A KO, and NELF-E KO groups; Right: Quantification of tumor weights; mean ± SEM, n = 4/group. Blots and images are representative of at least three independent experiments. Data in ( b – d ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    doi: 10.1038/s41467-023-38132-1

    Figure Lengend Snippet: a Western blot analysis of NELF-A and NELF-E in non-tumorigenic breast epithelial cell line MCF10A, as well as in different breast cancer cell lines T-47D (ER + , PR + ), SK-BR-3 (HER2 + ), MCF7 (ER + ), BT-474 (HER2 + ), BT-549 (triple-negative), MDA-MB-231 (triple-negative), and SUM159 (triple-negative). β-actin was used as the loading control. b , c Left: MCF7 cells ( n = 3) and BT-549 cells ( n = 4) were transfected with non-targeting siRNA (‘scrambled, siSCR’) and siRNAs targeting NELF-A and NELF-E, respectively, followed by western blot analysis. GAPDH was used as the loading control. Right: Representative images and quantification of soft agar assays. d Left: Western blot analysis of NELF-A, NELF-E, NELF-B, and NELF-C/D in WT and NELF-A/NELF-E KO SUM159 cells. β-actin was used as the loading control. Right: Representative images and quantification of soft agar assays ( n = 4). e 5 × 10 6 WT, NELF-A KO, and NELF-E KO SUM159 cells were injected into the mammary fat pads of NOD/SCID mice, respectively. Tumor volume was measured every 3 days after the tumor was palpable; mean ± SEM, n = 4/group. f Left: Tumors harvested from WT, NELF-A KO, and NELF-E KO groups; Right: Quantification of tumor weights; mean ± SEM, n = 4/group. Blots and images are representative of at least three independent experiments. Data in ( b – d ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.

    Article Snippet: Then, 200 μl of Dynabeads® Protein A (Thermo Fisher Scientific, 1002D) and 10 μg of NELF-E antibody (Abcam, ab170104) or Rabbit IgG antibody (Invitrogen, TH275005) were used for each sample.

    Techniques: Western Blot, Transfection, Injection, Two Tailed Test

    a MA plot showing gene expression changes between NELF-E KO and WT SUM159 cells. Red and blue points indicate significantly upregulated ( n = 388) and downregulated ( n = 540) genes, respectively. b GSEA enrichment plot for stemness and epithelial-mesenchymal transition pathways in NELF-E KO SUM159 cells. c Western blot analysis of NELF-E and NELF-A in WT, NELF-E KO, and NELF-E rescue SUM159 cells. β-actin was used as the loading control. d Quantification of wound healing assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells. Scale bar = 100 μm. e Quantification of mammosphere formation assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 4). Scale bar = 100 μm. f Quantification of invasion assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 3). Scale bar = 100 μm. g Body weight (mean ± SEM) of mice injected with 1.25 × 10 6 WT and NELF-E KO SUM159 cells, respectively ( n = 8, each group). h Lungs inflated and fixed with 10% neutral buffer formalin from mice in WT ( n = 8) and NELF-E KO group ( n = 8). i Representative images of H&E staining in lung tissues at three magnifications (mf: metastatic foci). From top to bottom, Bar = 2 mm, 500 μm, and 100 μm, respectively. j Quantitative analysis of lung metastasis presented as % of occupation by metastasis and the number of metastatic sites per lung ( n = 8/group). k Graph showing quantification of mammospheres in WT, NELF-E KO, and NELF-E rescue MCF7 cells at primary ( n = 3), secondary ( n = 4), and tertiary passages ( n = 4). l MCF7 cells from tertiary spheroids were seeded at a density of 1000 cells per well and incubated for 2 weeks. The colonies were then fixed and stained with crystal violet. m Flow cytometry analysis and quantification of the CD24 low /CD44 high population in MCF7 tertiary mammospheres ( n = 3). Blots and images are representative of at least three independent experiments. Data in ( d , e , f , j , k , m ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    doi: 10.1038/s41467-023-38132-1

    Figure Lengend Snippet: a MA plot showing gene expression changes between NELF-E KO and WT SUM159 cells. Red and blue points indicate significantly upregulated ( n = 388) and downregulated ( n = 540) genes, respectively. b GSEA enrichment plot for stemness and epithelial-mesenchymal transition pathways in NELF-E KO SUM159 cells. c Western blot analysis of NELF-E and NELF-A in WT, NELF-E KO, and NELF-E rescue SUM159 cells. β-actin was used as the loading control. d Quantification of wound healing assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells. Scale bar = 100 μm. e Quantification of mammosphere formation assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 4). Scale bar = 100 μm. f Quantification of invasion assay in WT, NELF-E KO, and NELF-E rescue SUM159 cells ( n = 3). Scale bar = 100 μm. g Body weight (mean ± SEM) of mice injected with 1.25 × 10 6 WT and NELF-E KO SUM159 cells, respectively ( n = 8, each group). h Lungs inflated and fixed with 10% neutral buffer formalin from mice in WT ( n = 8) and NELF-E KO group ( n = 8). i Representative images of H&E staining in lung tissues at three magnifications (mf: metastatic foci). From top to bottom, Bar = 2 mm, 500 μm, and 100 μm, respectively. j Quantitative analysis of lung metastasis presented as % of occupation by metastasis and the number of metastatic sites per lung ( n = 8/group). k Graph showing quantification of mammospheres in WT, NELF-E KO, and NELF-E rescue MCF7 cells at primary ( n = 3), secondary ( n = 4), and tertiary passages ( n = 4). l MCF7 cells from tertiary spheroids were seeded at a density of 1000 cells per well and incubated for 2 weeks. The colonies were then fixed and stained with crystal violet. m Flow cytometry analysis and quantification of the CD24 low /CD44 high population in MCF7 tertiary mammospheres ( n = 3). Blots and images are representative of at least three independent experiments. Data in ( d , e , f , j , k , m ) are presented as mean ± SD. p -values are determined by a two-tailed Student’s t -test. Source data are provided as a Source Data file.

    Article Snippet: Then, 200 μl of Dynabeads® Protein A (Thermo Fisher Scientific, 1002D) and 10 μg of NELF-E antibody (Abcam, ab170104) or Rabbit IgG antibody (Invitrogen, TH275005) were used for each sample.

    Techniques: Expressing, Western Blot, Wound Healing Assay, Tube Formation Assay, Invasion Assay, Injection, Staining, Incubation, Flow Cytometry, Two Tailed Test

    a Barplot showing the top perturbed pathways from Molecular Signatures Database (MSigDB) in Doxycycline (Dox)-treated MCF7ras+SS cells compared to the vehicle control. b Volcano plot depicting the significantly upregulated genes ( n = 1750) and downregulated genes ( n = 2223). Select mesenchymal/stemness-related genes are labeled in red, while epithelial genes are labeled in blue. adj. p -value ≤ 0.05; |fold change| ≥ 1.5. p -value was calculated using DESeq2 package (see details in “Methods”) c Western blot analysis for different markers in Dox-induced MCF7ras+SS cells transduced with scrambled or two independent shRNAs targeting NELF-E. GAPDH was used as the loading control. d GSEA plot of shNELF-E+Dox vs SCR+Dox cells. p -value was calculated from gene set enrichment analysis. (see detail in “Methods”). e Representative images and quantification of the migration and invasion assays. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA and treated with Dox to induce SOX9 and SLUG expression for 72 h prior to the assays ( n = 3). Scale Bar = 100 μm. f Representative images and quantification of the sphere-formation assay. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA, followed by 72-h Dox treatment. Cells were seeded at a density of 10K per well, and the number of spheres was counted 5–7 days later ( n = 4). Scale Bar = 100 μm. g Representative images and quantification of the soft agar assays for SCR+Dox and shNELF-E+Dox cells ( n = 3). h Flow cytometry analysis and quantification of the CD24 low /CD44 high population in NELF-E KD+Dox cells compared to SCR+Dox cells ( n = 3). Blots and images are representative of at least three independent experiments. p -values in ( e – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    doi: 10.1038/s41467-023-38132-1

    Figure Lengend Snippet: a Barplot showing the top perturbed pathways from Molecular Signatures Database (MSigDB) in Doxycycline (Dox)-treated MCF7ras+SS cells compared to the vehicle control. b Volcano plot depicting the significantly upregulated genes ( n = 1750) and downregulated genes ( n = 2223). Select mesenchymal/stemness-related genes are labeled in red, while epithelial genes are labeled in blue. adj. p -value ≤ 0.05; |fold change| ≥ 1.5. p -value was calculated using DESeq2 package (see details in “Methods”) c Western blot analysis for different markers in Dox-induced MCF7ras+SS cells transduced with scrambled or two independent shRNAs targeting NELF-E. GAPDH was used as the loading control. d GSEA plot of shNELF-E+Dox vs SCR+Dox cells. p -value was calculated from gene set enrichment analysis. (see detail in “Methods”). e Representative images and quantification of the migration and invasion assays. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA and treated with Dox to induce SOX9 and SLUG expression for 72 h prior to the assays ( n = 3). Scale Bar = 100 μm. f Representative images and quantification of the sphere-formation assay. MCF7ras+SS cells were transduced with scrambled or NELF-E shRNA, followed by 72-h Dox treatment. Cells were seeded at a density of 10K per well, and the number of spheres was counted 5–7 days later ( n = 4). Scale Bar = 100 μm. g Representative images and quantification of the soft agar assays for SCR+Dox and shNELF-E+Dox cells ( n = 3). h Flow cytometry analysis and quantification of the CD24 low /CD44 high population in NELF-E KD+Dox cells compared to SCR+Dox cells ( n = 3). Blots and images are representative of at least three independent experiments. p -values in ( e – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Article Snippet: Then, 200 μl of Dynabeads® Protein A (Thermo Fisher Scientific, 1002D) and 10 μg of NELF-E antibody (Abcam, ab170104) or Rabbit IgG antibody (Invitrogen, TH275005) were used for each sample.

    Techniques: Labeling, Western Blot, Transduction, Migration, shRNA, Expressing, Tube Formation Assay, Flow Cytometry, Two Tailed Test

    a Log 2 fold change of UP-genes ( n = 1750), DOWN-genes ( n = 2223), and unchanged genes ( n = 1581) in the two different conditions. Gene categorization was based on the condition of SCR+Dox vs SCR-Con with the cutoffs of adj. p -value ≤ 0.05 and |fold change| ≥ 1.5. Center lines show median values, box limits represent the upper and lower quartiles, and whiskers show 1.5× the interquartile range. Two-tailed Student’s t -tests were used for all comparisons. p -values were not adjusted for multiple tests, and t -statistics are provided in source data. b Genomic distribution of NELF-E binding sites in Dox-treated MCF7ras+SS cells. c Metagene plots of NELF-E ChIP-seq signals in SCR-Con and SCR+Dox cells for UP-genes (top panel) and DOWN-genes (bottom panel). d Metagene plots of RNAPII ChIP-seq signals in SCR-Con, SCR+Dox, and shNELF-E+Dox cells for UP-genes and DOWN-genes. e Genome browser tracks showing NELF-E and RNAPII occupancies at the promoters of mesenchymal gene FN1 (left) and stemness-related gene CD44 (right). Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    doi: 10.1038/s41467-023-38132-1

    Figure Lengend Snippet: a Log 2 fold change of UP-genes ( n = 1750), DOWN-genes ( n = 2223), and unchanged genes ( n = 1581) in the two different conditions. Gene categorization was based on the condition of SCR+Dox vs SCR-Con with the cutoffs of adj. p -value ≤ 0.05 and |fold change| ≥ 1.5. Center lines show median values, box limits represent the upper and lower quartiles, and whiskers show 1.5× the interquartile range. Two-tailed Student’s t -tests were used for all comparisons. p -values were not adjusted for multiple tests, and t -statistics are provided in source data. b Genomic distribution of NELF-E binding sites in Dox-treated MCF7ras+SS cells. c Metagene plots of NELF-E ChIP-seq signals in SCR-Con and SCR+Dox cells for UP-genes (top panel) and DOWN-genes (bottom panel). d Metagene plots of RNAPII ChIP-seq signals in SCR-Con, SCR+Dox, and shNELF-E+Dox cells for UP-genes and DOWN-genes. e Genome browser tracks showing NELF-E and RNAPII occupancies at the promoters of mesenchymal gene FN1 (left) and stemness-related gene CD44 (right). Source data are provided as a Source Data file.

    Article Snippet: Then, 200 μl of Dynabeads® Protein A (Thermo Fisher Scientific, 1002D) and 10 μg of NELF-E antibody (Abcam, ab170104) or Rabbit IgG antibody (Invitrogen, TH275005) were used for each sample.

    Techniques: Two Tailed Test, Binding Assay, ChIP-sequencing

    a Volcano plot of NELF-E qPLEX-RIME analysis of WT+Dox vs WT-Con. Proteins that satisfy the significance threshold of |log 2 (fold change)| ≥0.5 and adj. p -value <0.05 are labeled with their gene names and colored red. The p -value was adjusted by Benjamini–Hochberg multiple hypothesis correction. b Interaction network plot of proteins enriched in Dox induction by qPLEX-RIME, superimposed on the STRING interaction network. Interactions detected by qPLEX-RIME are colored in blue, while interactions from the STRING database are colored in gray. Proteins/nodes are colored based on log 2 (fold change) value. c Western blot analysis of SOX9, SLUG, and NELF-E following NELF-E immunoprecipitation (IP), performed on nuclear extracts from Dox-treated MCF7ras+SS cells. Blots are representative of three independent experiments. d Genomic distribution of SLUG binding sites in MCF7ras+SS cells transduced with scrambled shRNA and treated with Dox (SCR+Dox). e Metaplots of SLUG binding across the three different categories in SCR+Dox and shNELF-E+Dox MCF7ras+SS cells. f , g Pie chart and heatmap depiction of SLUG and NELF-E co-bound peaks at TSS and distal regions. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    doi: 10.1038/s41467-023-38132-1

    Figure Lengend Snippet: a Volcano plot of NELF-E qPLEX-RIME analysis of WT+Dox vs WT-Con. Proteins that satisfy the significance threshold of |log 2 (fold change)| ≥0.5 and adj. p -value <0.05 are labeled with their gene names and colored red. The p -value was adjusted by Benjamini–Hochberg multiple hypothesis correction. b Interaction network plot of proteins enriched in Dox induction by qPLEX-RIME, superimposed on the STRING interaction network. Interactions detected by qPLEX-RIME are colored in blue, while interactions from the STRING database are colored in gray. Proteins/nodes are colored based on log 2 (fold change) value. c Western blot analysis of SOX9, SLUG, and NELF-E following NELF-E immunoprecipitation (IP), performed on nuclear extracts from Dox-treated MCF7ras+SS cells. Blots are representative of three independent experiments. d Genomic distribution of SLUG binding sites in MCF7ras+SS cells transduced with scrambled shRNA and treated with Dox (SCR+Dox). e Metaplots of SLUG binding across the three different categories in SCR+Dox and shNELF-E+Dox MCF7ras+SS cells. f , g Pie chart and heatmap depiction of SLUG and NELF-E co-bound peaks at TSS and distal regions. Source data are provided as a Source Data file.

    Article Snippet: Then, 200 μl of Dynabeads® Protein A (Thermo Fisher Scientific, 1002D) and 10 μg of NELF-E antibody (Abcam, ab170104) or Rabbit IgG antibody (Invitrogen, TH275005) were used for each sample.

    Techniques: Labeling, Western Blot, Immunoprecipitation, Binding Assay, Transduction, shRNA

    a Dot plot showing KAT2B as one of the top genes ( n = 41) whose SLUG-mediated activation was most significantly attenuated by NELF-E KD. Expressions of corresponding genes in the two comparisons are connected by gray lines. b Genome browser tracks showing the occupancies of NELF-E, SLUG, and RNAPII on the KAT2B locus. c RT-qPCR analysis (left) and western blot analysis (right) of KAT2B in MCF7ras+SS cells treated with Dox for different time points ( n = 3). d Western blot analysis of KAT2B in MCF7ras+SS cells transduced with scrambled shRNA or two independent NELF-E shRNAs and treated with or without Dox. GAPDH was used as the loading control. e Heatmap depiction of SLUG/NELF-E/KAT2B/RNAPII signals at NELF-E-alone, SLUG-alone and NELF-E/SLUG co-bound regions. f Metaplot of KAT2B ChIP-Seq signals over the different cohorts of SLUG-bound regions. g Venn diagram showing the overlap between SLUG-bound UP-genes and NELF-E/KAT2B targets. The percentage overlap of SLUG-bound UP-genes compared to other categories is also indicated. h Genome browser tracks showing the occupancies of NELF-E, SLUG, and KAT2B on LAMC1 and ZEB1 loci. Blots are representative of three independent experiments. p -values are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    doi: 10.1038/s41467-023-38132-1

    Figure Lengend Snippet: a Dot plot showing KAT2B as one of the top genes ( n = 41) whose SLUG-mediated activation was most significantly attenuated by NELF-E KD. Expressions of corresponding genes in the two comparisons are connected by gray lines. b Genome browser tracks showing the occupancies of NELF-E, SLUG, and RNAPII on the KAT2B locus. c RT-qPCR analysis (left) and western blot analysis (right) of KAT2B in MCF7ras+SS cells treated with Dox for different time points ( n = 3). d Western blot analysis of KAT2B in MCF7ras+SS cells transduced with scrambled shRNA or two independent NELF-E shRNAs and treated with or without Dox. GAPDH was used as the loading control. e Heatmap depiction of SLUG/NELF-E/KAT2B/RNAPII signals at NELF-E-alone, SLUG-alone and NELF-E/SLUG co-bound regions. f Metaplot of KAT2B ChIP-Seq signals over the different cohorts of SLUG-bound regions. g Venn diagram showing the overlap between SLUG-bound UP-genes and NELF-E/KAT2B targets. The percentage overlap of SLUG-bound UP-genes compared to other categories is also indicated. h Genome browser tracks showing the occupancies of NELF-E, SLUG, and KAT2B on LAMC1 and ZEB1 loci. Blots are representative of three independent experiments. p -values are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Article Snippet: Then, 200 μl of Dynabeads® Protein A (Thermo Fisher Scientific, 1002D) and 10 μg of NELF-E antibody (Abcam, ab170104) or Rabbit IgG antibody (Invitrogen, TH275005) were used for each sample.

    Techniques: Activation Assay, Quantitative RT-PCR, Western Blot, Transduction, shRNA, ChIP-sequencing, Two Tailed Test

    a GSEA plot showing significantly enriched pathways in siKAT2B+Dox vs siSCR+Dox MCF7ras+SS cells. p -value was calculated from gene set enrichment analysis (see details in “Methods”). b Western blot analysis of ECM1 and CD44 in MCF7ras+SS cells treated with or without GA and AA. GAPDH was used as the loading control. Images and blots are representative of three independent experiments. c qRT-PCR analysis of FN1 and ECM1 in GA- and AA-treated Dox-induced MCF7ras+SS cells ( n = 3). d Flow cytometry analysis and quantification of the CD24 low /CD44 high population in vehicle control, GA-, and AA-treated MCF7ras+SS cells, as a function of Dox induction. e Flow cytometry analysis and quantification of the CD24 low /CD44 high population following KAT2B overexpression in MCF7ras+SS cells. Vector control (GFP only; pCAGIG) and KAT2B-overexpression (KAT2B+GFP; pCAGIG-KAT2B) plasmids were transfected into MCF7ras+SS cells, respectively. The GFP − and GFP + populations were isolated and analyzed for the CD24 low /CD44 high population ( n = 3). f , g Patient-derived breast cancer organoids were transduced with scrambled shRNA or two independent KAT2B or NELF-E shRNAs, followed by western blot and sphere-formation assay ( n = 3). β-actin was used as the loading control. h Patient-derived breast cancer organoids were transduced with vector control or KAT2B overexpressing plasmid, followed by western blot and sphere-formation assay ( n = 4). GAPDH was used as the loading control. Blots and images are representative of at least three independent experiments. p -values in ( c – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis

    doi: 10.1038/s41467-023-38132-1

    Figure Lengend Snippet: a GSEA plot showing significantly enriched pathways in siKAT2B+Dox vs siSCR+Dox MCF7ras+SS cells. p -value was calculated from gene set enrichment analysis (see details in “Methods”). b Western blot analysis of ECM1 and CD44 in MCF7ras+SS cells treated with or without GA and AA. GAPDH was used as the loading control. Images and blots are representative of three independent experiments. c qRT-PCR analysis of FN1 and ECM1 in GA- and AA-treated Dox-induced MCF7ras+SS cells ( n = 3). d Flow cytometry analysis and quantification of the CD24 low /CD44 high population in vehicle control, GA-, and AA-treated MCF7ras+SS cells, as a function of Dox induction. e Flow cytometry analysis and quantification of the CD24 low /CD44 high population following KAT2B overexpression in MCF7ras+SS cells. Vector control (GFP only; pCAGIG) and KAT2B-overexpression (KAT2B+GFP; pCAGIG-KAT2B) plasmids were transfected into MCF7ras+SS cells, respectively. The GFP − and GFP + populations were isolated and analyzed for the CD24 low /CD44 high population ( n = 3). f , g Patient-derived breast cancer organoids were transduced with scrambled shRNA or two independent KAT2B or NELF-E shRNAs, followed by western blot and sphere-formation assay ( n = 3). β-actin was used as the loading control. h Patient-derived breast cancer organoids were transduced with vector control or KAT2B overexpressing plasmid, followed by western blot and sphere-formation assay ( n = 4). GAPDH was used as the loading control. Blots and images are representative of at least three independent experiments. p -values in ( c – h ) are determined by a two-tailed Student’s t -test. Mean ± SD is represented by bar graphs. Source data are provided as a Source Data file.

    Article Snippet: Then, 200 μl of Dynabeads® Protein A (Thermo Fisher Scientific, 1002D) and 10 μg of NELF-E antibody (Abcam, ab170104) or Rabbit IgG antibody (Invitrogen, TH275005) were used for each sample.

    Techniques: Western Blot, Quantitative RT-PCR, Flow Cytometry, Over Expression, Plasmid Preparation, Transfection, Isolation, Derivative Assay, Transduction, shRNA, Tube Formation Assay, Two Tailed Test